发明名称 Fused aminodihydrothiazine derivatives
摘要 A compound represented by the general formula:; or a pharmaceutically acceptable salt thereof or a solvate thereof, wherein Ring A is a C6-14 aryl group or the like, L is —NReCO— or the like (wherein Re is a hydrogen atom or the like), Ring B is a C6-14 aryl group or the like, X is a C1-3 alkylene group or the like, Y is a single bond or the like, Z is a C1-3 alkylene group or the like, R1 and R2 are each independently a hydrogen atom or the like, and R3, R4, R5 and R6 are independently a hydrogen atom, a halogen atom or the like, has an Aβ production inhibitory effect or a BACE1 inhibitory effect and is useful as a prophylactic or therapeutic agent for a neurodegenerative disease caused by Aβ and typified by Alzheimer-type dementia.
申请公布号 US8946211(B2) 申请公布日期 2015.02.03
申请号 US201313804691 申请日期 2013.03.14
申请人 Eisai R&D Management Co., Ltd. 发明人 Suzuki Yuichi;Motoki Takafumi;Kaneko Toshihiko;Takaishi Mamoru;Ishida Tasuku;Kita Yoichi;Takeda Kunitoshi;Yamamoto Noboru;Khan Afzal;Dimopoulos Paschalis
分类号 C07D513/02;A61K31/542 主分类号 C07D513/02
代理机构 Fish & Richardson P.C. 代理人 Fish & Richardson P.C.
主权项 1. A compound represented by the formula:or a pharmaceutically acceptable salt thereof, wherein: R3 and R4 are independently selected from the group consisting of H and C1-6 alkyl, wherein the C1-6 alky is optionally substituted by 1, 2, or 3 substituents; R7a, R7b, and R7C are independently selected from the group consisting of H and X; R8a, R8b, and R8C are independently selected from the group consisting of H, X, CHmXn, and OCHmXn; wherein m is 0, 1, or 2; n is 1, 2, or 3; and X is halogen selected from the group consisting of fluorine, chlorine, bromine and iodine.
地址 Tokyo JP